Introduction
============

Engineered carbon nanotubes (CNTs) are a class of graphene cylinders of 1 or more layers with at least 1 external dimension between 1 and 100 nm.[@b1-ijn-12-1019] These characteristics impart unique electrical, mechanical, and thermal properties that make CNTs exceedingly valuable for a range of biomedical and commercial applications, including solar cells, adhesives, polymer composites, lithium-ion batteries, drug delivery, and medical diagnostics.[@b2-ijn-12-1019] As a result, CNT production has increased about 10-fold since 2006[@b3-ijn-12-1019] to a global output of \>2,000 tons in 2013.[@b4-ijn-12-1019]

Concomitant with the increase in production of CNTs has been a growing urgency to understand the risks posed by occupational exposure to these nanoparticles.[@b2-ijn-12-1019] Of the 2 major subtypes of CNTs (ie, single-walled and multiwalled), multiwalled CNTs (MWCNTs) represent \>99% of global production volume.[@b5-ijn-12-1019] In addition to the marked production disparity between CNT subtypes, evidence suggests that the toxicity of MWCNTs is greater than that of single-walled CNTs.[@b6-ijn-12-1019] However, other factors also augment CNT toxicity, including the presence of residual catalyst contamination from synthesis (eg, Ni, Fe, others),[@b7-ijn-12-1019] surface modifications,[@b8-ijn-12-1019]--[@b10-ijn-12-1019] and length.[@b11-ijn-12-1019] Among these other factors, length is particularly important as longer MWCNTs have been suggested to contribute to inflammation and fibrosis in a manner similar to asbestos fibers.[@b12-ijn-12-1019] Lung macrophages are important targets for MWCNTs.[@b11-ijn-12-1019],[@b13-ijn-12-1019],[@b14-ijn-12-1019] Thus, understanding how these cells respond to exposure is important for understanding the mechanisms underlying MWCNT-induced lung disease.

Matrix metalloproteinases (MMPs) comprise a family of 27 distinct, but structurally related, extracellular endopeptidases. Since the first MMP was isolated from regressing tadpole tails, they have oft been assumed to function in the breakdown of extracellular matrix (ECM).[@b15-ijn-12-1019] However, while some MMPs do serve defined or limited roles in ECM turnover, this is far from being the biggest role or predominant function of these enzymes. For example, in vivo findings with genetically engineered mice have shown that MMPs are critical regulators of innate immunity by controlling leukocyte influx and activation, restoration of tissue barriers, and cleavage of latent cytokines, chemokines, and antimicrobial agents, among many other processes.[@b16-ijn-12-1019],[@b17-ijn-12-1019] Like several MMPs, MMP-10 is not expressed in unchallenged tissues, but in response to a variety of insults, including injury and infection, it is induced by macrophages and epithelial cells in many organs, including the lung.[@b18-ijn-12-1019]--[@b21-ijn-12-1019] Studies with *Mmp10*^−/−^ mice indicate that MMP-10 functions to control the activation status of macrophages.[@b18-ijn-12-1019],[@b22-ijn-12-1019],[@b23-ijn-12-1019]

In this study, we report a protective role for macrophage MMP-10 in the acute pulmonary response to MWCNTs. We found that following aspiration of long MWCNTs into the lung, expression of MMP-10 was induced, and promoted clearance of these nanoparticles from the lung, and mononuclear cell survival, and moderated inflammation and airway fibrosis. Using bone marrow-derived macrophages (BMDMs) and alveolar macrophages, we demonstrate that macrophages respond to MWCNT exposure by initiating pro-inflammatory and apoptotic responses that are moderated by MMP-10.

Materials and methods
=====================

Animals
-------

*Mmp10*^−/−^ mice (on a C57BL/6J genetic background)[@b19-ijn-12-1019] and wild-type littermates (male and female, 8--12 weeks old) were used for these studies. All animal-handling procedures were performed according to the Guide for the Care and Use of Laboratory Animals (8th edition) of the National Research Council (National Academy of Sciences, USA) and followed the guidelines of the US Animal Welfare Act. Specific treatments and procedures were approved by the Office of Animal Welfare at the University of Washington and by the Institutional Animal Care and Use Committee at Cedars-Sinai Medical Center.

MWCNTs
------

MWCNTs were purchased from Cheap Tubes, Inc. (Cambridgeport, VT, USA) and provided to the University of Washington's Nanotoxicology Center through participation in the NIEHS Centers for Nanotechnology Health Implications Research (NCNHIR) Consortium. Tube preparation for both in vivo and in vitro work consisted of suspension in dispersion medium (DM) that consisted of 0.6 mg/mL mouse serum albumin, 10 µg/mL 1,2-dipalmitoyl-sn-glycero-3-phosphocholine, and 0.1% ethanol (v/v) in PBS. Stock aliquots of MWCNTs (1.6 µg/µL) were sonicated for 19 s in a 40 kHz Branson 2510DTH bath sonicator (Branson Ultrasonics Corp., Danbury, CT, USA), and the solution was vortexed for 1 s both during preparation and immediately before treatments. Details of particle preparation and electron microscopy images were recently published.[@b24-ijn-12-1019] The manufacturer's product data specified an outer diameter of 10--20 nm and a length of 10--30 µm. Scanning electron microscopy with energy dispersive X-ray spectroscopy analysis (SEMEDS), conducted by the National Cancer Institute Nanotechnology Characterization Laboratory, confirmed an elemental composition of 95.8%±0.6% (SD) carbon and 3.4%±0.2% oxygen and the presence of trace amounts of Ni (0.5%±0.5%) and Fe (0.3%±0.3%). These values are consistent with their composition determined by Pulskamp et al.[@b7-ijn-12-1019]

Exposures and tissue harvest
----------------------------

Mice (6/exposure group/genotype) were treated with a 50 µL oropharyngeal aspiration of DM or an equivalent volume containing 80 µg of MWCNTs. Mice were sacrificed 24 h later, and the left lung was occluded, flash frozen, and homogenized in either RIPA or RLT buffer (Qiagen, Valencia, CA, USA) for protein and RNA analyses. Bronchoalveolar lavage (BAL) was collected from the right lung, and total cells were identified and counted via an automated cell counter. The right lung was then inflated with 600 µL of 10% neutral buffered formalin and prepared for histology as described by Braber et al.[@b25-ijn-12-1019] Fixed lungs were paraffin-embedded, sectioned, and stained with H&E by the Cedars-Sinai Medical Center Biobank & Translational Research Core (BTRC).

MWCNT clearance
---------------

Using captured images of H&E-stained sections, the BTRC then set a threshold value with DM-alone sections to eliminate artifacts and blindly assessed both the MWCNT aggregate count and the percentage of area occupied (in pixels) in each treated lung section (n=6). These findings were supported by our own counts obtained with microscopy (10×).

Macrophage cell culture
-----------------------

BMDMs and alveolar macrophages were isolated and cultured under sterile techniques as described in detail by McMahan et al[@b23-ijn-12-1019] and Manicone et al.[@b26-ijn-12-1019] Briefly, for BMDMs, marrow from femurs and tibias of wild-type and *Mmp10*^−/−^ mice was recovered by brief centrifugation. Red blood cells were removed by adding lysis buffer (eBio-science, San Diego CA, USA). The remaining cells were suspended in Mac medium (RPMI 1640 with 10% fetal bovine serum and 20% medium conditioned by L929 cells as a source of CSF-1) and plated at 1.5×10^6^ cells/10 cm plate. Mac medium was replaced on days 3 and 6. Between days 7 and 10, plates were washed with PBS to remove nonadherent or dead cells. The macrophages were then removed from the plate using 5 mM ETDA in PBS, and cell counts and viability analysis were determined. Alveolar macrophages were isolated from BAL by centrifugation, pooled in pairs, and treated with 100 µg/mL of MWCNTs in low serum medium (RPMI 1640 + 2% FBS) for 2 or 24 h. Polymyxin B sulfate salt (10 µg/mL; Sigma-Aldrich, St Louis, MO, USA) was included in experimental treatments to control for potential lipopolysaccharide contamination.

Particle uptake
---------------

In vivo estimates of endocytosis were calculated from BAL cytospin slides. MWCNT-positive cells were identified by light microscopy, and percentages were determined from averages of 4 separate counts of 100 cells. The total number of MWCNT-positive cells was back-calculated from total cell estimates. In vitro endocytosis was determined in a similar manner following 3 h of MWCNT exposure. The average area occupied by MWCNT-positive vacuoles per cell was quantified from 30 measurements per animal at ×80 utilizing Digital Image Hub software version 4.0.4 (Leica Microsystems GmbH, Buffalo Grove, IL, USA).

Assays
------

Caspase-3 activity in lung and cell lysates was assayed using a Caspase-3 Colorimetric Assay Kit (Biovision, Milpitas, CA, USA) according to the manufacturer's instructions. Myeloperoxidase (MPO) activity was measured in lung lysates and BAL cell pellets using the EnzChek Myeloperoxidase Activity Assay Kit (Life Technologies, Carlsbad, CA, USA). Total RNA was isolated from lung homogenates and cultured macrophages. Total RNA was isolated (Qiagen, Valencia, CA, USA), and specific transcripts were quantified by real-time PCR using TaqMan FAM-labeled probes (Applied Biosystems, Foster City, CA, USA) as described by Rohani et al.[@b27-ijn-12-1019] Total IL-1β levels were measured using the Mouse IL-1β ELISA Ready-SET-Go! Kit (eBioscience).

Statistics
----------

Statistical analyses included either multiple *t*-test or two-way ANOVA where appropriate using Prism 5 (GraphPad Software, La Jolla, CA, USA). Bonferroni posttest was used to account for multiple comparisons. All data are presented as mean ± standard error of the mean (SEM), except where indicated, and a *P*-value of \<0.05 was considered significant.

Results
=======

MWCNT-induced expression of MMP-10
----------------------------------

To elucidate the impact of MMP-10 on the pulmonary response to MWCNTs, wild-type (*Mmp10*^+^*/*^+^) and *Mmp10*^−/−^ mice were treated with 80 µg of MWCNTs by oropharyngeal aspiration or with an equivalent volume of DM. This dose of MWCNT was based on exposures used on other studies.[@b28-ijn-12-1019]--[@b30-ijn-12-1019] Lungs were collected 24 h later and processed for mRNA isolation. In lungs from unchallenged wild-type mice (ie, no MWCNTs, no DM alone), we detected a Ct range for *Mmp10* mRNA between 36 and 37 indicating essentially no or very low levels of expression. Expression of *Mmp10* was modestly induced by administration of DM alone, indicating that the treatment procedure caused a mild lung injury, which is common among treatment methods that involve direct instillation into the lung. However, when exposed to MWCNTs, expression of *Mmp10* mRNA was stimulated \>3-fold above DM-control levels ([Figure 1A](#f1-ijn-12-1019){ref-type="fig"}). As expected, *Mmp10* mRNA was not detected in *Mmp10*^−/−^ samples (data not shown).

Impact on inflammatory cells
----------------------------

Total cells in BAL did not differ between unchallenged wild-type and *Mmp10*^−/−^ mice ([Figure 1B](#f1-ijn-12-1019){ref-type="fig"}) and nearly all of these (\>90%) were macrophages ([Figure 1C](#f1-ijn-12-1019){ref-type="fig"}). In response to DM, total cells in BAL increased modestly, but still did not differ significantly between genotypes ([Figure 1B](#f1-ijn-12-1019){ref-type="fig"}). However, when treated with MWCNTs, the total cell count was reduced relative to the controls and was significantly lower in *Mmp10*^−/−^ samples ([Figure 1B](#f1-ijn-12-1019){ref-type="fig"}). Differential cell counts revealed no significant differences in the percentage or total numbers of lymphocytes between genotypes and treatments. In contrast, we found a reduced percentage and number of macrophages, as well as a higher percentage of neutrophils in MWCNT-treated *Mmp10*^−/−^ BAL compared to wild-type BAL ([Figure 1C and D](#f1-ijn-12-1019){ref-type="fig"}). However, though elevated by MWCNTs, the total numbers of neutrophils did not differ significantly between wild-type and *Mmp10*^−/−^ mice ([Figure 1C](#f1-ijn-12-1019){ref-type="fig"}). Similarly, we assayed expression levels of *Cxcl1* ([Figure S1A](#SD1-ijn-12-1019){ref-type="supplementary-material"}), which encodes CXCL1/KC, the murine ortholog of human CXCL8/IL-8 and a critical acute-phase neutrophil chemokine.[@b31-ijn-12-1019] Consistent with our neutrophil estimates ([Figure 1C and D](#f1-ijn-12-1019){ref-type="fig"}), we found that MWCNT treatment stimulated increased *Cxcl1* expression and that this increase showed only a mild trend toward being greater in *Mmp10*^−/−^ mice.

We also assessed if reduced chemokine expression contributed to lowered macrophage numbers in *Mmp10*^−/−^ mice. As with *Cxcl1*, *Ccl2* levels increased significantly with MWCNT treatment, but did not differ between wild-type and *Mmp10*^−/−^ mice ([Figure S1B](#SD1-ijn-12-1019){ref-type="supplementary-material"}). These findings suggest that the reduced macrophage numbers in MWCNT-treated *Mmp10*^−/−^ mice were due to a loss of cells rather than impaired recruitment. Overall, these findings indicate that MWCNTs mediated a pro-inflammatory response that was manifested by both an increase in neutrophil numbers and a reduction in macrophages. While both of these observations were exaggerated in *Mmp10*^−/−^ mice, only the reduction of macrophages was statistically significant.

MWCNTs induce production of pro-inflammatory factors
----------------------------------------------------

Many groups have demonstrated that MWCNTs induce a robust pro-inflammatory response following instillation into the lung, including *Il1b*, *Il6*, *Tnfa*,[@b32-ijn-12-1019] and *Nos2* mRNAs.[@b33-ijn-12-1019] Therefore, we assessed each of these mRNAs in the lungs of wild-type and *Mmp10*^−/−^ mice ([Figure 2](#f2-ijn-12-1019){ref-type="fig"}). We found that the mRNA levels for *Il6* and *Nos2* were increased in MWCNT-treated mice and that their levels did not differ between wild-type and *Mmp10*^−/−^ mice. Though expression of *Il1b* trended toward an increase in total lung RNA, the increase did not reach significance. *Tnfa* and mRNA levels were not affected. Consistent with these observations, we did not observe differences in pulmonary hemorrhage or total BAL protein, both markers of acute lung injury, between genotypes ([Figure S2](#SD2-ijn-12-1019){ref-type="supplementary-material"}).

Given that the most prominent response in the cell counts was a reduction in macrophage numbers, we hypothesized that total lung transcripts might be masking an underlying pro-inflammatory phenotype in macrophages. Therefore, we used BMDMs from wild-type and *Mmp10*^−/−^ mice to assess if the observed in vivo responses to MWCNTs could be attributed to macrophages. In all in vitro experiments, we added 10 µg/mL of PmB to control for possible endotoxin contamination. Mirroring what we observed in vivo, treatment of BMDMs for 2 h with 10--100 µg/mL of MWCNTs resulted in a statistically significant increase in *Mmp10* mRNA vs DM control ([Figure 3A](#f3-ijn-12-1019){ref-type="fig"}). In addition, we found that MWCNT stimulated expression of mRNAs for *Il1β*, *Il6*, *Il12a*, and *Tnfa* in wild-type cells and that these values were elevated further in *Mmp10*^−/−^ BMDMs ([Figure 3B](#f3-ijn-12-1019){ref-type="fig"}). Release of IL-1β protein from wild-type macrophages was also induced by MWCNTs -- but not by DM -- and was significantly increased from *Mmp10*^−/−^ macrophages ([Figure 3C](#f3-ijn-12-1019){ref-type="fig"}).

MMP-10 facilitates clearance of MWCNTs
--------------------------------------

As macrophages are critical for clearing inhaled particles, we assessed if the reduced numbers of macrophages in *Mmp10*^−/−^ mice impacted retention of MWCNTs. Indeed, in lung homogenates we observed more MWCNT particles in *Mmp10*^−/−^ lysate pellets compared to wild-type samples, and this difference between genotypes remained evident at 28 d postexposure ([Figure 4A](#f4-ijn-12-1019){ref-type="fig"}). Other groups have found that inhaled MWCNTs persist in the lung for up to 1 year postexposure.[@b34-ijn-12-1019],[@b35-ijn-12-1019] In addition, in sections of *Mmp10*^−/−^ lung we observed an accumulation of particles in alveolar macrophages ([Figure 4B](#f4-ijn-12-1019){ref-type="fig"}). By both internal counts ([Figure 4A](#f4-ijn-12-1019){ref-type="fig"}) and blinded morphometric analysis ([Figure 4C and D](#f4-ijn-12-1019){ref-type="fig"}), we measured significantly more (about 2.5-fold) retained particles ([Figure 4D](#f4-ijn-12-1019){ref-type="fig"}) and a greater percentage of total tissue occupied by MWCNT ([Figure 4E](#f4-ijn-12-1019){ref-type="fig"}) in *Mmp10*^−/−^ lungs compared to wild-type tissue. No particle signal was visible ([Figure 4B](#f4-ijn-12-1019){ref-type="fig"}) or detected in the DM-control lungs (data not shown).

Despite an overall increase in retained particles in lungs, we did not find a difference in either the percentage of MWCNT-containing macrophages ([Figure 5A and B](#f5-ijn-12-1019){ref-type="fig"}) or average MWCNT-occupied area in endocytic vacuoles between wild-type and *Mmp10*^−/−^ samples ([Figure 5C](#f5-ijn-12-1019){ref-type="fig"}). However, in both genotypes we found an inverse relationship between macrophage numbers and the percentage of MWCNT-positive macrophages, but this negative correlation was more robust in *Mmp10*^−/−^ samples ([Figure 5D](#f5-ijn-12-1019){ref-type="fig"}). These data suggest that MMP-10 is involved in mediating both protection against macrophage cell death and particle clearance from the lung post-MWCNT exposure.

MMP-10 protects against MWCNT-mediated apoptosis in macrophages
---------------------------------------------------------------

As the number of resident macrophages did not differ between unchallenged wild-type and *Mmp10*^−/−^ mice ([Figure 1C and D](#f1-ijn-12-1019){ref-type="fig"}), we assessed if the reduction of macrophages observed in *Mmp10*^−/−^ mice was due to MWCNT-induced apoptosis of these cells. Caspase-3 activity, which is an established end point of MWCNT-induced cell death,[@b13-ijn-12-1019],[@b36-ijn-12-1019] in lung lysates was not affected by MWCNT exposure and did not differ between wild-type and *Mmp10*^−/−^ mice ([Figure 6A](#f6-ijn-12-1019){ref-type="fig"}). However, we saw about a 2-fold increase in caspase-3 activity in BAL from MWCNT-treated *Mmp10*^−/−^ mice compared to the levels measured in wild-type samples ([Figure 6B](#f6-ijn-12-1019){ref-type="fig"}). We assessed if macrophages were responsible for the robust increase in caspase-3 activity in the cellular fraction of *Mmp10*^−/−^ BAL. In agreement with our in vivo findings, we found that while the number of MWCNT-positive macrophages did not differ between wild-type and *Mmp10*^−/−^ mice ([Figure 7A](#f7-ijn-12-1019){ref-type="fig"}), MWCNTs mediated a significantly greater increase in caspase-3 activity in *Mmp10*^−/−^ BMDM ([Figure 7B](#f7-ijn-12-1019){ref-type="fig"}). These data suggest that MMP-10 protects macrophages from MWCNT-induced apoptosis.

Because macrophages that influx into the lung -- or any tissue -- are distinct from the resident population,[@b37-ijn-12-1019]--[@b39-ijn-12-1019] we assessed if wild-type and *Mmp10*^−/−^ alveolar macrophages responded similar to MWCNT exposure as did BMDM, which model the recruited cell population. As we saw with BMDM ([Figure 3A](#f3-ijn-12-1019){ref-type="fig"}), expression of *Mmp10* was significantly upregulated in wild-type alveolar macrophages exposed to MWCNT ([Figure 8A](#f8-ijn-12-1019){ref-type="fig"}). In addition, we saw a marked release of IL-1β from both wild-type and *Mmp10*^−/−^ alveolar macrophages ([Figure 8B](#f8-ijn-12-1019){ref-type="fig"}), which trended (*P*=0.161) to be greater from *Mmp10*^−/−^ cells, similar to the responses we saw with BMDM ([Figure 3C](#f3-ijn-12-1019){ref-type="fig"}). Furthermore, we found that whereas MWCNTs did not affect caspase-3 activity in wild-type alveolar macrophages, they did mediate nearly a 3-fold increase in *Mmp10*^−/−^ cells ([Figure 8C](#f8-ijn-12-1019){ref-type="fig"}). These data support the conclusion that both resident alveolar macrophages and infiltrating macrophages respond similarly to MWCNT and that Mmp-10 has a protective role in both populations by moderating MWCNT-induced macrophage apoptosis.

Discussion
==========

Despite their growing usage, much uncertainty still exists regarding the risks associated with respiratory CNT exposure. This is particularly true of occupational exposures during transfer, weighing, and blending,[@b2-ijn-12-1019] but the stability of these particles suggests that environmental CNT exposures will also become more important as the CNT market continues its transition from R&D to high-volume production.[@b40-ijn-12-1019]--[@b42-ijn-12-1019] In this study, we report that MMP-10 serves a beneficial function during the acute-phase response to MWCNT by promoting clearance and moderating the pro-inflammatory, fibrotic, and apoptotic effects of MWCNT in both resident alveolar macrophages and BMDM.

Although the dosages utilized here are greater than what might be expected to occur in an occupational setting,[@b43-ijn-12-1019] they are consistent with other high-dose studies meant to uncover the mechanism(s) of MWCNT toxicity.[@b28-ijn-12-1019],[@b44-ijn-12-1019],[@b45-ijn-12-1019] While the majority of in vivo studies have focused on the long-term impact of exposure, less attention has been paid to factors that impact acute innate immune responses. This is particularly important point as macrophage apoptosis and inflammation are associated with disease in various lung models,[@b46-ijn-12-1019],[@b47-ijn-12-1019] including CNTs.[@b48-ijn-12-1019]

Consistent with other studies, we found that oropharyngeal aspiration of 80 µg/mouse of MWCNTs initiated a robust damage response.[@b30-ijn-12-1019],[@b44-ijn-12-1019],[@b49-ijn-12-1019] Compared to DM controls, MWCNT-treated mice exhibited enhanced pulmonary hemorrhage, edema, neutrophilia, and macrophage cell death, as well as accumulations of MWCNTs in BAL macrophages at 24 h postexposure. In addition, mRNA analyses revealed an upregulation of multiple pro-inflammatory transcripts including *Il6*, *Nos2*, and notably, *Il1β*, which is important in the initiation of MWCNT-induced pathology.[@b50-ijn-12-1019] Interestingly, *Mmp10* mRNA was also found to be present in this milieu.

Further analyses revealed that absence of *Mmp10* in vivo was associated with enhanced mononuclear cell death and a 2- to 3-fold impairment in pulmonary clearance of MWCNTs. Given the role of endocytosis in mediating pulmonary clearance from the distal lung,[@b51-ijn-12-1019] we investigated if macrophage phagocytosis could explain the difference in clearance between wild-type and *Mmp10*^−/−^ mice. However, both in vivo and cell culture analysis indicated no difference in the per-cell phagocytosis of MWCNTs between genotypes. One possible explanation for the difference in clearance between genotypes is that the increase in apoptosis of *Mmp10*^−/−^ macrophages leads to fewer functional macrophages and, in turn, reduced clearance of inhaled nanoparticles. However, our data with BMDMs do not fully support this idea. As macrophage-mediated clearance of particles is thought to be secondary to mucociliary clearance,[@b51-ijn-12-1019] MMP-10 may be influencing this mucosal function. Future studies will explore the mechanistic basis for MMP-10-dependent particle clearance from lung.

Our in vivo data indicate that MMP-10 provides a protective response to macrophages by reducing their sensitivity to MWCNT-induced inflammation and cell death. In other words, while the number of positive mononuclear cells in BAL did not differ between wild-type and *Mmp10*^−/−^ mice, macrophage loss was more strongly associated with the presence of MWCNT in *Mmp10*^−/−^ mice than in wild types. These in vivo findings were confirmed in vitro with both BMDMs and alveolar macrophages. These experiments demonstrated that *Mmp10*^−/−^ macrophages expressed higher levels of *Il6* and *Il1b* transcripts, as well as IL-1β protein in response to MWCNTs, and that this expression was associated with an enhanced, dose-dependent death of these cells in culture. With respect to mechanism, we propose that MMP10 sheds a protein on the surface of macrophages and that this proteolytic processing mediates outside-in signaling that affects the activation state of these cells and expression of inflammatory mediators. Because we observed overlapping responses in macrophages both in vivo and in cell culture,[@b18-ijn-12-1019],[@b23-ijn-12-1019] it is likely that MMP10 controls macrophage activation via a cell autonomous mechanism. Although we do not yet know the critical substrate, identifying this macrophage protein is a major goal of our group.

Conclusion
==========

Macrophages are critical responders to MWCNT exposure, a finding that is consistent with other in vivo[@b30-ijn-12-1019],[@b52-ijn-12-1019] and in vitro studies.[@b8-ijn-12-1019] In addition, our group and others have shown that *Mmp10* is a critical determinant of macrophage responses and differentiation status in models of acute colon injury,[@b22-ijn-12-1019] skin wounds,[@b18-ijn-12-1019] and lung infection with *Pseudomonas aeruginosa*.[@b23-ijn-12-1019] Notably, in both the skin wound and lung infection models, adoptive transfer of wild-type macrophages into *Mmp10*^−/−^ mice was sufficient to rescue the principal phenotypes (excess scar in skin wounds; morbidity in lung infection) observed in *Mmp10*^−/−^ animals. While the exact mechanism(s) underlying this response is unknown (ie, the substrate MMP-10 acts on to control macrophage function), these studies all concluded that Mmp-10 is an important modifier of macrophage activation in injured tissues. In the present study, we extend these observations by reporting a role for macrophage Mmp-10 in the acute response to MWCNT exposure. In addition, our findings raise questions about the long-term impact of MMP-10 in affecting responses to MWCNT exposure.

Supplementary materials
=======================

###### 

Macrophage and neutrophil recruitment is MWCNT treatment dependent, but not genotype dependent.

**Notes:** Total RNA was collected from lung homogenates, and *Cxcl1* (**A**) and *Ccl2* (**B**) transcripts were then quantified. HPRT was used as an internal control, and values are expressed as a fold change from DM-treated WT mice. \*Significant change relative to DM-treated control mice (*P*\<0.05).

**Abbreviations:** MWCNT, multiwalled carbon nanotube; DM, dispersion medium; WT, wild-type; HPRT, hypoxanthine phosphoribosyltransferase.

###### 

Acute lung injury post-MWCNT exposure is independent of MMP-10.

**Notes:** (**A**) H&E lung sections showing areas of pulmonary hemorrhage in MWCNT-treated and DM-control WT and *Mmp*10^−/−^ lungs at ×5 magnification. (**B**) Total protein quantification in BAL collected post-MWCNT and DM exposure.

**Abbreviations:** MWCNT, multiwalled carbon nanotube; MMP, matrix metalloproteinase; DM, dispersion medium; WT, wild-type; BAL, bronchoalveolar lavage; Unt, untreated.
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![MMP-10 protects against MWCNT-associated losses of macrophages.\
**Notes:** WT and *Mmp10*^−/−^ mice (n=6) were administered 80 µg of L-MWCNT in 50 µL DM or an equivalent volume of DM alone (n=3) by oropharyngeal aspiration or were untreated (Unt.). Lungs were harvested 24 h later. (**A**) qPCR for *Mmp10* mRNA was performed on total RNA collected from WT lung homogenates. HPRT was used for an internal control, and data are presented as fold change from the mean DM expression level. BAL was collected, and total cells were quantified by cell counter. (**B**) Cytospins were stained with DiffQuick, and (**C**) total and (**D**) percentages of macrophages, neutrophils, and lymphocytes were determined via light microscopy. Data were analyzed by multiple *t*-test. \*Significant change relative to DM control. ^\#^Significant change relative to MWCNT-treated WT mice (*P*\<0.05).\
**Abbreviations:** MMP, matrix metalloproteinase; MWCNT, multiwalled carbon nanotube; WT, wild-type; L-MWCNT, long MWCNT; DM, dispersion medium; qPCR, quantitative polymerase chain reaction; BAL, bronchoalveolar lavage; Unt, untreated; HPRT, hypoxanthine phosphoribosyltransferase.](ijn-12-1019Fig1){#f1-ijn-12-1019}

![MWCNTs induce robust lung inflammation.\
**Notes:** *Il6* (**A**), *Il1b* (**B**), *Nos2* (**C**), and *Tnfa* (**D**) transcripts were measured in total RNA from the lungs of WT and *Mmp10*^−/−^ mice treated with MWCNTs or DM. Data are expressed as fold change from that of DM-treated WT mice. Data were analyzed by two-way ANOVA. \*Significant change relative to DM-treated WT mice (*P*\<0.05).\
**Abbreviations:** MWCNT, multiwalled carbon nanotube; WT, wild-type; DM, dispersion medium; ANOVA, analysis of variance.](ijn-12-1019Fig2){#f2-ijn-12-1019}

![MMP-10 attenuates the pro-inflammatory response to MWCNT in BMDMs.\
**Notes:** (**A**) BMDMs (n=3) were treated with 10, 50, or 100 µg/mL of MWCNT or an equivalent volume of DM for 2 h, and *Mmp10* expression was assayed by qPCR. (**B**) WT and *Mmp10*^−/−^ BMDMs were treated for 2 h with 100 µg/mL MWCNT or DM, and levels of *Il1b*, *Tnfa*, *Il6*, and *Il12a* transcripts were measured. (**C**) Total Il-1β protein was quantified by ELISA in pooled samples (n=3). Error is expressed as SD; data were analyzed by multiple *t*-test. ^†^Samples below the detection limit. \*Significance vs nontreated WT mice; ^\#^significance vs MWCNT-treated WT mice. All transcripts were quantified using HPRT as an internal control, and values were expressed relative to untreated controls (*P*\<0.05).\
**Abbreviations:** MMP, matrix metalloproteinase; MWCNT, multiwalled carbon nanotube; BMDMs, bone marrow-derived macrophages; DM, dispersion medium; qPCR, quantitative polymerase chain reaction; WT, wild-type; ELISA, enzyme-linked immunosorbent assay; Cont, Control; HPRT, hypoxanthine phosphoribosyltransferase.](ijn-12-1019Fig3){#f3-ijn-12-1019}

![*Mmp10*^−/−^ mice exhibit reduced MWCNT clearance.\
**Notes:** (**A**) WT and *Mmp10*^−/−^ lungs were homogenized in RIPA buffer and centrifuged at 18,000 rpm for 10 min. (**B**) Right lung lobes from treated mice were formalin-fixed, paraffin embedded, sectioned, and stained with H&E. Arrows indicate the presence of MWCNTs in lung sections visible at ×5 and ×20 magnifications. (**C**) Total aggregates/right lung slide (n=6) were counted by light microscopy. Slides, each containing 4 lobe sections, were independently scanned by the CS-BTRC, and total aggregates (**D**) and percentage of occupied area (**E**) were blindly quantified. Data were analyzed by multiple *t*-test. \*Significant change relative to MWCNT-treated WT lungs (*P*\<0.05).\
**Abbreviations:** MWCNT, multiwalled carbon nanotube; WT, wild-type; CS-BTRC, Cedars-Sinai Medical Center Biobank & Translational Research Core.](ijn-12-1019Fig4){#f4-ijn-12-1019}

![MWCNT sensitivity in *Mmp10*^−/−^ mice is mediated by contact but not enhanced endocytosis.\
**Notes:** (**A**) ×40 image of BAL cytospins demonstrating colocalization of MWCNTs to macrophages (arrows). (**B**) Percentages of MWCNT-positive cells were obtained from averages of 4 counts of 100 cells/slide. (**C**) The average area occupied by MWCNT-positive vacuoles per cell was quantified from 30 measurements per mouse using Digital Image Hub software version 4.0.4. (**D**) Linear regression demonstrating the relationship between percentage macrophages and MWCNT-positive cells in WT and *Mmp10*^−/−^ mice. Data were analyzed by multiple *t*-test (*P*\<0.05).\
**Abbreviations:** MWCNT, multiwalled carbon nanotube; BAL, bronchoalveolar lavage; WT, wild-type; MØ, macrophage.](ijn-12-1019Fig5){#f5-ijn-12-1019}

![MWCNTs are associated with enhanced caspase-3 activity in *Mmp10*^−/−^ BAL pellets but not in lung tissue.\
**Notes:** Caspase-3 activity was quantified in lysates from lung (**A**) or the cellular fraction of BAL at 24 h postexposure (**B**). Values are expressed relative to DM-treated WT mice. Data were analyzed by multiple *t*-test. \*Significance vs DM-treated WT mice; ^\#^significance vs MWCNT-treated WT mice (*P*\<0.05).\
**Abbreviations:** MWCNT, multiwalled carbon nanotube; BAL, bronchoalveolar lavage; DM, dispersion medium; WT, wild-type.](ijn-12-1019Fig6){#f6-ijn-12-1019}

![Absence of Mmp-10 confers sensitivity to apoptosis in BMDMs without an increase in endocytosis.\
**Notes:** (**A**) WT and *Mmp10*^−/−^ BMDMs (n=3) were treated with 10 µg/mL of MWCNTs for 3 h and percentages of MWCNT-positive cells were obtained from averages of 4 counts of 100 cells/well. (**B**) Caspase-3 activity was determined in WT and *Mmp10*^−/−^ BMDMs following 24-h treatment with 10, 50, and 100 µg/mL of MWCNTs, or DM, and expressed as fold change relative to untreated controls. Data were analyzed by multiple *t*-test. \*Significant change from DM-treated WT BMDMs, ^\#^significant change from MWCNT-treated WT BMDMs (*P*\<0.05).\
**Abbreviations:** MMP, matrix metalloproteinase; BMDMs, bone marrow-derived macrophages; MWCNT, multiwalled carbon nanotube; DM, dispersion medium; WT, wild-type.](ijn-12-1019Fig7){#f7-ijn-12-1019}

![*Mmp10* protects alveolar macrophages against inflammation and apoptosis post-MWCNT exposure.\
**Notes:** Alveolar macrophages were collected from naïve WT and *Mmp10*^−/−^ mice (n=3/genotype) and treated with 100 µg/mL of MWCNTs. (**A**) qPCR was performed for *Mmp10* mRNA after 2- and 24-h exposures. Conditioned media and cell lysates were collected at 24 h posttreatment and assayed for IL-1β (**B**) and caspase-3 activity (**C**). Data were analyzed by multiple *t*-test. \*Significant change relative to WT control (**A**) or WT MWCNT-treated samples (**C**).\
**Abbreviations:** MWCNT, multiwalled carbon nanotube; qPCR, quantitative polymerase chain reaction; WT, wild-type; Unt, untreated.](ijn-12-1019Fig8){#f8-ijn-12-1019}
